Table 2.
Cytokine | Organism | Setting | Target | Effect | Ref. |
---|---|---|---|---|---|
CYTL1 | in vitro Human, in vivo Mice | Escherichia coli infection | phosphorylation of protein kinase B (Akt) | enhanced phagocytosis | [113] |
IL-6 | Mice | Staphylococcus aureus infection | phosphorylation of STAT3 | augmented the uptake of bacteria and phagosome acidification | [114] |
IL-6 | Human | Staphylococcus aureus infection | n.i. | enhanced phagocytosis and stimulated ROS generation | [115] |
IL-10 | Mice | Escherichia coli induced meningitis | increased expression of CR3 | enhanced phagocytosis | [116] |
IL-12 | Mice | polymicrobial sepsis induced by cecal ligation and puncture (CLP) | induction of IFNγ | enhanced phagocytosis | [117] |
IL-17 | Mice | Candida albicans induced sepsis, and zymosan-induced multiple organ failure | n.i. | enhanced phagocytosis | [118] |
IL-18 | Mice | polymicrobial sepsis induced by cecal ligation and puncture (CLP) | n.i. | did not affect phagocytosis | [117] |
IL-34 | in vitro Human, in vivo Mice | sepsis | n.i. | enhanced phagocytosis | [119] |
n.i.—not identified.